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140a Sunday, February 26, 2012fibrosis and CD31 immunostaining for cardiac angiogenesis were performed. A
p<0.05 was considered significant. Values were mean5SE. LP was associated
with heart hypertrophy (p<0.05 vs. NP) that was reversed 7-days PP (heart
weight: NP=12053, LP= 16352, PP1= 14552, PP7= 11751 mg). Con-
versely, heart weight/body weight (hw/bw) ratio was decreased in LP
(p<0.05 vs. NP) that was reversed in PP1 (hw/bw: NP=5.950.1, LP=
4.550.1, PP1= 5.650.1). LV ejection fraction was reduced in LP (p<0.05
vs. NP) and was also restored at PP1 (NP=7454, LP= 5751, PP1=
7351%). Cardiac angiogenesis was significantly increased in LP (p<0.001
vs. NP), and was fully restored in PP7 (p<0.001 vs. LP) (Capillary density:
NP=0.9550.01, LP=1.2550.02, PP7=0.9850.01 capillaries/myocyte). Simi-
larly, VEGF was upregulated in LP, and was restored in PP7 (NP=150.1,
LP=1.4 50.1, PP7=0.8350.1). There was no increase in cardiac fibrosis
in pregnancy-induced heart hypertrophy. Transcript levels of extracellular
matrix (ECM) degrading enzyme MMP2 were downregulated in LP (p<0.05
vs. NP) and were restored at 7-days PP (NP=150.01, LP=0.4750.03,
PP7=0.7050.1). In conclusion, pregnancy-induced heart hypertrophy is asso-
ciated with increased cardiac angiogenesis, lack of fibrosis, decreased MMP2
and decreased diastolic function of the heart that are reversed postpartum.
We speculate that physiologic heart hypertrophy of pregnancy has minimal
cardiac ECM remodeling.
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Pulmonary hypertension (PH) is a characterized by arterial obstruction result-
ing from proliferation of pulmonary artery smooth muscle and endothelial cells.
Genetic deletion of apolipoprotein-A1 increases airway hyperresponsiveness,
inflammation, and collagen deposition in the lung. Apolipoprotein-A1 mimetic
peptide 4F protects endothelial function, causes vasodilation, decreases inflam-
mation and oxidative stress in lungs, yet its role in treating PH and right ven-
tricular (RV) dysfunction is not known. We hypothesized that 4F may rescue
pre-existing severe PH. We also investigate the effects of 4F on human pulmo-
nary artery smooth muscle cell (hPASMC) proliferation in vitro as a possible
mechanism of rescue by 4F. Twenty three rats were randomly divided into
4-groups. PH was induced by monocrotaline (MCT, 60mg/kg, s.c.). Severe
PH was well-established at day-21 (PH, n=6) that progressed to RV failure
(RVF, n=6) by day-30. One MCT-group was treated with 4F (50mg/kg/day,
s.c., n=6) from day-21 to 30. Saline-treated rats served as control (CTRL,
n=5). Serial echocardiography was performed to monitor cardiopulmonary he-
modynamics. Cardiac catheterization was performed terminally to record RV-
pressure (RVP). hPASMCs proliferation was assessed by MTT-assay. p<0.05
was considered significant. Values were mean5SE. Rats developed severe
PH 21-days after MCT (RVP=67.1251 vs. 29.851 mmHg in CTRL, RV/
LVþIVS= 0.6550.05 vs. 0.2350.02, RV-ejection fraction (RVEF)= 4051
vs. 6551%, all p<0.05 vs. CTRL), which progressed to RVF by day-30
[RVP=7451; RV/(LVþIVS)=0.6850.05; RVEF=28.651%, p<0.05 for all
vs. CTRL]. 4F-therapy from day-21 to 30 resulted in rescue of PH
(RVP=4753 mmHg, RV/LVþIVS= 0.3850.02, RVEF= 51.753%, p<0.05
vs. PH and RVF). 4F also inhibited hPASMC proliferation (~60% inhibition
at 100ng 4F/ml medium, p<0.05). In conclusion, 4F rescues pre-existing severe
PH and RV-dysfunction. Inhibition of PASMC proliferation may be one of the
key mechanisms in this rescue.
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Pulmonary Hypertension (PH) is a disease of increasing pulmonary arterial
pressure characterized by extensive lung inflammation and fibrosis. We have
previously shown that Genistein, a soy isoflavone, can rescue severe PH. Since
Genistein is a selective Estrogen Receptor Beta agonist, here we examined
whether Genistein can reverse fibrosis and inflammation induced by PH via
an Estrogen Receptor Beta dependent mechanism. PH was established by treat-
ing male rats with monocrotaline (MCT, 60mg/kg, s.c.). At day 21 when severe
PH was established, rats were treated with 10 day Genistein therapy (Gen
group), Genistein therapy in the presence of selective Estrogen Receptor
b antagonist PHTPP (GenþPHTPP group), or were left untreated to develop
right ventricular failure (RVF group). RVF animals developed severe pulmo-nary hypertension (RVP=72.9651.39mmHg vs 31.1550.56 mmHg in
CTRL; RVEF=28.7650.79% vs 66.2251.40% in CTRL, all p<.05). Genis-
tein therapy restored these abnormalities (RVEF=65.6751.08%, RVP ¼
43.3454.08 mmHg, p<0.05 vs RVF). Interestingly, in the presence of
Estrogen Receptor Beta antagonist PHTPP, Genistein failed to rescue these
animals (RVP=61.2254.40, RVEF=42.2752.7%, p=n.s. vs RVF). Masson’s
Trichrome staining revealed extensive lung fibrosis in RVF group, which
was also restored with Gen therapy. Again, GenþPHTPP group showed no
reversal of pulmonary fibrosis. Immunoperoxidase staining showed an increase
in ED-1 positive cells in the lung of RVF-group indicating increased inflamma-
tion. This change was reversed entirely by Genistein therapy. RT PCR also
revealed that pro-inflammatory molecules TNFa and IL-1b were both elevated
more than 2-fold in the lung of RVF animals and reversed with Genistein
therapy (all p<0.05). Interestingly, GenþPHTPP animals still showed signifi-
cantly elevated ED-1 positive cells in the lung as well as elevated TNFa and
IL1b (all p=n.s. vs RVF). These results suggest that genistein induced reversal
of lung inflammation and fibrosis during pulmonary hypertension is mediated
through Estrogen Receptor b.
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Heart failure is generally characterized by increased fibrosis and inflammation,
which lead to functional and contractile defects. Recently we discovered that
estrogen (E2) therapy can rescue advanced heart failure (HF) induced by pres-
sure overload in mice by restoring left ventricular (LV) pressure and function.
Here, we investigate the effects of E2 on reversing the adverse remodeling of
the LV occurring during HF. Trans-aortic constriction procedure was used
to induce HF. Once the ejection fraction reached ~30%, one group of
mice was sacrificed and the other group was treated with E2 (30 mg/kg/day)
for 10 days. In vitro, co-cultured neonatal rat ventricular myocytes and
fibroblasts were treated with angiotensin II (AngII) in the presence or absence
of E2. Quantitative real-time PCR showed that the transcript levels of the pro-
fibrotic markers collagen I, TGFb, fibrosin 1 (FBRS) and lysil oxidase (LOX)
were significantly upregulated in HF (from 1.0050.16 to 1.8350.11for
collagen 1, 1.0050.86 to 4.3350.59 for TGFb, 1.0050.52 to 3.6150.22
for FBRS and 1.0050.33 to 2.8850.32 for LOX) and were reduced with E2
treatment to levels similar to CTRL. In vitro studies validated our in vivo find-
ings, as E2 also restored AngII-induced upregulation of LOX and TGFb from
6.8750.26 in AngII to 2.8051.5 in AngIIþE2 and 3.3050.25 to 1.5950.21
in AngIIþE2, respectively (values normalized to CTRL). Furthermore, the pro-
inflammatory interleukins IL-1b and IL-6 were upregulated from 1.0050.19 to
1.9050.09 and 1.0050.30 to 5.2950.77 in HF, respectively, and reversed to
CTRL levels with E2 therapy. The anti-inflammatory interleukin IL-10 was
downregulated from 1.0050.17 to 0.4950.03 in HF and reversed to
0.6750.09 with E2 treatment. This data strongly suggests that one of the mech-
anisms for the beneficial action of estrogen on left ventricular heart failure is
through reversal of inflammation and fibrosis.
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Pulmonary hypertension (PH) leads to right-ventricular hypertrophy and failure
(RVF). RVF involves adverse remodeling of the ventricular extracellular
matrix (ECM). Recently we found that estrogen (E2) rescues PH-induced
RVF. Here we explore whether the rapid restoration of RV function by E2 ther-
apy during PH-induced RVF is in part due to a direct effect of E2 on the adverse
ECM remodeling of the RV. In vivo, rats were injected with monocrotaline. At
day 21, when PH had established, rats either received E2 (E2-group) for 10
days or were left untreated to develop RVF (RVF-group). In vitro, co-
cultured neonatal rat ventricular myocytes and fibroblasts were treated with
Angiotensin II in the presence or absence of E2 (AngII and AngIIþE2 resp.).
In vivo, E2 reversed RV fibrosis (4.0650.52% in CTRL, 3353.2 in RVF,
5.6650.33% in E2 group, all P<.05). In vitro, E2 similarly inhibited AngII in-
duced increase in Collagen I transcript in cultured myocytes and fibroblasts
(1.4950.04 in AngII, 0.7550.04 in AngIIþE2, normalized to CTRL,
p<.05). In vivo, E2 reversed PH induced increases of ECM remodeling en-
zymes OPN, ADAM15 and ADAM17 in the RV (9.3352.07 in RVF,
0.4550.16 in E2 for OPN; 2.1350.19 in RVF, 0.4750.07 in E2 for
Sunday, February 26, 2012 141aADAM15; 1.8550.04 in RVF, 1.350.14 in E2 for ADAM17. All normalized
to resp. CTRL, all p<0.05). In vitro, E2 also reversed expression of these genes
induced by Angiontensin II (2.7450.19 in AngII, 1.7250.01 in AngIIþE2 for
OPN; 1.3150.06 in AngII, 0.8850.02 in AngIIþE2 for ADAM15; 1.5550.01
in AngII, 1.0950.002 in AngIIþE2 for ADAM17. All normalized to resp.
CTRL, all p<0.05). E2 therapy was associated with complete reversal of RV
fibrosis and changes in OPN, ADAM15 and ADAM17 expression. This data
indicates that E2 has a direct effect on mitigating the adverse remodeling of
the RV during PH.
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Mouse heart possesses three types of estrogen (E2) receptors, ERa, ERb and
the G-protein coupled estrogen receptor1 (GPER1). We previously reported
that rapid E2-induced cardioprotection is abrogated in GPER1-/-, and that
this action is mediated by pERK1/2 and pGSK-3b stimulation in absence of
pAkt increase.
Here, we investigated the potential role of ERa, and ERb in mediating the rapid
cardioprotective action of E2 in ischemia/reperfusion injury in male mice, and
further corroborated the role ERK1/2 and GSK-3b without the participation
PI3K/Akt pathway.
We first quantified mRNA absolute levels of the three receptors in heart, and
found that ventricles express much higher levels of GPER1 than ERa and
ERb. E2 (40 nM) treatment in the Langendorff model of ischemia/reperfusion
improved cardiac functional recovery, reduced infarct size, and increased
calcium-retention-capacity (a measure of mitochondrial transition pore,
mPTP, opening) to the same degree in WT, ERa-/- and ERb-/-, further confirm-
ing no role of ERa and ERb in rapid E2-induced cardioprotection. As previ-
ously reported, these beneficial effects were completely abrogated in
GPER1-/-. The involvement of MAPK-ERK1/2 pathway is further supported
by the loss of E2-induced increase of calcium-retention-capacity by treatment
with U01261, an ERK1/2 pathway inhibitor. The rapid E2 action did not in-
volve PI3K pathway as the E2-induced pGSK-3b high level was not affected
by treatment with LY294002, a PI3K inhibitor.
In summary, in male mice, only GPER1 activation mediates the rapid
E2-induced cardioprotection against ischemia/reperfusion injury via phosphor-
ylation of ERK1/2 and GSK-3b leading to increased mitochondrial calcium-
retention-capacity reflecting a reduction of mPTP opening. Supported by
NIH and AHA.
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The heart from a diabetic animal exhibits dysfunction when exposed to chal-
lenging energetic and tissue redox conditions. We showed that when cardio-
myocytes from type-2 diabetes (db/db) mice are exposed to high glucose
(HG) and b-adrenergic stimulation (via isoproterenol, ISO), these cells show
blunted b-contractile reserve and increased oxidative stress. Treating these
cells with the fatty acid (FA) palmitate (Palm) offsets those changes, an effect
likely due to its ability of generating more reducing equivalents. Yet whether
Palm infusion may benefit contractile performance and vascular tone of db/
db hearts subjected to metabolic/redox stress is unclear. Using a Langendorff
approach, we perfused wild type (WT) and db/db mice with HG (30mM glu-
cose) þ ISO (10nM), in absence or presence of Palm. WT hearts were infused
with 0.2mM Palm and db/db ones with 0.4mM Palm to mimic higher circulat-
ing FA content in diabetic animals. Under HG, coronary perfusion pressure
(CPP) was higher in db/db hearts (9258 vs. 6357 mmHg, p<0.05). This in-
crease in tone was obviated by Palm. WT had better myocardial performance
than db/db mice. For instance, dP/dtmax was 46535460 in WT vs 3474 5
185 mmHg/sec in db/db (p<0.05). Although markedly blunted, ISO responsewas still present in db/db hearts (2821583 vs 34745185 mmHg/sec,
p<0.05). However, HG fully blocked ISO-response. Infusing Palm to db/db
preserved ISO response under HG (23925505 vs 31065425 mmHg/sec,
p<0.05). Our study reveals that preferential FA oxidation improves heart LV
function in diabetic mice subjected to combined energetic and redox challenge.
This beneficial effect of Palm may be due to glucose-to-FA substrate shift and
also to improved redox balance as shown in isolated cardiomyocytes.
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The mechanisms underlying the homeostasis of ATP, ADP, PCr and inorganic
phosphate in heart under a wide range of workloads remain unclear. Fundamen-
tal to this search is an accurate understanding of the recycling fluxes of these
metabolites between the mitochondrial inner membrane space and the ATPases
on both the myofibrils and SERCA pumps. In addition to 31P-NMR inversion
and saturation transfer studies, dynamic 18O labeling data has been used to an-
alyze energy transfer. An integrative kinetic model that tracks the mass iso-
topomers of these four metabolites was constructed with the following
compartments: mitochondrial matrix, mitochondrial intermembrane space, cy-
tosol, and enzyme bound states of both ATPase and ATP synthase (since these
reactions are not unidirectional with respect to oxygen exchange). A sensitivity
analysis of this system was conducted with a jump to 30% H2
18O to find flux
parameters that influenced the 18O labeling state. Both the creatine kinase
and adenylate kinase shuttle fluxes were modeled as being bidirectional to
test assumptions made in previous studies that analyzed dynamic 18O labeling
data.
It was found that the sum of forward and reverse fluxes through each shuttle
determined the labeling state such that if the sum is kept constant and the net
flux is reduced, a very similar labeling state is predicted. Total creatine kinase
and adenylate kinase fluxes that exceeded the ATP synthase rate were also
found to give almost the same predictions of the labeling state. Model predic-
tions of the 18O labeling state of metabolites are very similar using energy
fluxes reported in earlier studies of 18O labeling in the heart and energy transfer
analysis by 31P-NMR inversion and saturation transfer.
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Mice hearts were perfused using Langendorff apparatus with Krebs-Henseleit
(KH) buffer oxygenated with 95% O2 þ 5% CO2 at 37C. Hearts were main-
tained suspended in the air in the humid chamber at 37oC for 20 min. Thereaf-
ter, hearts were either immersed in KH or kept in air in the same chamber at
37 C, and subjected to 18 min of global ischemia by clamping the aorta.
Afterwards, hearts were returned to air in the same humid chamber for 40,
60 or 90 min reperfusion. Heart function was monitored and myocardial infarc-
tion assessed by TTC staining at the end of the reperfusion. ROS generation
was measured with Amplex Red in mitochondria isolated after 10 min of
reperfusion.
When the hearts were immersed in KH, heart function and infarct size had
reached an injured steady-state at 40 min of reperfusion. In contrast, hearts
kept in air had a smaller reperfusion injury and infarct size at 40 and 60 min
approaching steady-state at 90 min after reperfusion. Consistent with a lower
injury in air, mitochondrial ROS production by stimulating complex I was
much smaller in air-maintained than in immersed hearts. We tested whether
increased oxygenation of the ventricle heart walls in the immersed heart might
be the cause of higher damage. To reduce oxygen, the KH solution was bubbled
with N2 only. In this condition, the cardiac functional recovery was improved,
and the infarct size measured at 60 min after reperfusion was reduced. In con-
clusion, 40 min reperfusion is sufficient to reach a steady-state infarct size when
the hearts are immersed in KH during ischemia, while longer reperfusion time
is required if the hearts kept in air. The injury installation during the reperfusion
depends on the oxygen surrounding the heart during ischemia. Supported by
NIH and AHA.
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ROS generation has been implicated in cardiac damage during ischemia/reper-
fusion injury, and also in cardioprotection by preconditioning with a series of
